Loading...
Bayer AG
BAYN.DE•XETRA
HealthcareDrug Manufacturers - General
€26.43
€0.005(0.02%)
Bayer AG (BAYN.DE) Financial Performance & Statements
Review Bayer AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-2.16%
↓ 2.16%
Operating Income Growth
2318.00%
↑ 2318.00%
Net Income Growth
13.23%
↑ 13.23%
Operating Cash Flow Growth
43.99%
↑ 43.99%
Operating Margin
6.36%
↑ 6.36%
Gross Margin
53.99%
↑ 53.99%
Net Profit Margin
-6.98%
↓ 6.98%
ROE
-9.96%
↓ 9.96%
ROIC
3.65%
↑ 3.65%
Bayer AG (BAYN.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Bayer AG stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.73B | $9.97B | $11.14B | $13.77B |
| Cost of Revenue | $5.72B | $5.09B | $4.99B | $5.46B |
| Gross Profit | $6.006B | $4.88B | $6.15B | $8.30B |
| Gross Profit Ratio | $0.51 | $0.49 | $0.55 | $0.60 |
| R&D Expenses | $1.73B | $1.56B | $1.50B | $1.43B |
| SG&A Expenses | $4.33B | $3.73B | $3.72B | $3.63B |
| Operating Expenses | $2.47B | $4.88B | $5.22B | $5.05B |
| Total Costs & Expenses | $8.20B | $9.97B | $10.21B | $10.52B |
| Interest Income | $138.00M | $150.00M | $95.00M | $161.00M |
| Interest Expense | $385.00M | $642.00M | $682.00M | $648.00M |
| Depreciation & Amortization | $1.77B | $4.76B | $1.14B | $1.11B |
| EBITDA | $1.67B | $1.06B | $1.76B | $4.37B |
| EBITDA Ratio | $0.14 | $0.11 | $0.16 | $0.32 |
| Operating Income | $3.53B | -$3.82B | $930.00M | $3.25B |
| Operating Income Ratio | $0.30 | -$0.38 | $0.08 | $0.24 |
| Other Income/Expenses (Net) | -$4.01B | -$525.00M | -$1.03B | -$643.00M |
| Income Before Tax | -$481.00M | -$4.35B | -$97.00M | $2.60B |
| Income Before Tax Ratio | -$0.04 | -$0.44 | -$0.009 | $0.19 |
| Income Tax Expense | -$153.00M | -$153.00M | -$71.00M | $589.00M |
| Net Income | -$335.00M | -$4.18B | -$34.00M | $2.00B |
| Net Income Ratio | -$0.03 | -$0.42 | -$0.003 | $0.15 |
| EPS | -$0.34 | -$4.26 | -$0.03 | $2.04 |
| Diluted EPS | -$0.34 | -$4.26 | -$0.03 | $2.04 |
| Weighted Avg Shares Outstanding | $982.42M | $982.42M | $982.42M | $982.42M |
| Weighted Avg Shares Outstanding (Diluted) | $982.42M | $982.42M | $982.42M | $982.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan